GAFFX
Price
$76.01
Change
+$0.28 (+0.37%)
Updated
May 22 closing price
Net Assets
297.16B
GSTSX
Price
$9.87
Change
+$0.04 (+0.41%)
Updated
May 22 closing price
Net Assets
186.56M
Interact to see
Advertisement

GAFFX vs GSTSX

Header iconGAFFX vs GSTSX Comparison
Open Charts GAFFX vs GSTSXBanner chart's image
American Funds Growth Fund of Amer F3
Price$76.01
Change+$0.28 (+0.37%)
VolumeN/A
Net Assets297.16B
Goldman Sachs Strategic Growth Svc
Price$9.87
Change+$0.04 (+0.41%)
VolumeN/A
Net Assets186.56M
GAFFX vs GSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. GSTSX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and GSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 297B vs. GSTSX (187M). GAFFX pays higher dividends than GSTSX: GAFFX (0.70) vs GSTSX (0.00). GAFFX was incepted earlier than GSTSX: GAFFX (8 years) vs GSTSX (26 years). GSTSX (1.46) is less costly to investors than GAFFX (0.30). GSTSX is a more actively managed with annual turnover of: 39.00 vs. GAFFX (25.00). GSTSX has a lower initial minimum investment than GAFFX: GSTSX (0) vs GAFFX (1000000). GSTSX (6.85) and GAFFX (6.73) have marching annual gain over last year. GAFFX return over 5 years is better than : 49.43 vs. GSTSX (12.86).
GAFFXGSTSXGAFFX / GSTSX
Total Expense Ratio0.301.2524%
Annual Report Gross Expense Ratio0.301.4621%
Fund Existence8 years26 years-
Gain YTD2.068-2.092-99%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets297B187M158,824%
Annual Yield % from dividends0.700.00-
Returns for 1 year6.736.8598%
Returns for 3 years40.7431.59129%
Returns for 5 years49.4312.86384%
Returns for 10 yearsN/A-21.04-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRAW1.260.06
+5.00%
Traws Pharma Inc
FOXA55.14N/A
N/A
Fox Corp
PTGX45.82N/A
N/A
Protagonist Therapeutics
LASR13.45N/A
N/A
nLIGHT
HITI2.30N/A
N/A
High Tide